test

Robert Grundstein

@Sabby Management, Llc

Latest period2024 - Q3ReportedManaged Assets$186.418MTotal holdings42
Assets growth rate-99.87%Assets growth rate (2-Q avg)-57.03%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Sabby Management, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 42 positions.

Assets under management

The assets under management (AUM) of Sabby Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 186.418M in assets, with a quarterly growth rate of -99.87% and a 2-quarter average growth rate of -57.03%. The portfolio is managed by Robert Grundstein, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
PHIOPhio Pharmaceuticals Corp
Recent Activity
New Position
0.05%
$86,702
25,131 shares@ $3.46 avg price
NRXPNrx Pharmaceuticals Inc
Recent Activity
New Position
0.04%
$59,233
35,049 shares@ $1.7 avg price
VVOSVivos Therapeutics Inc
Recent Activity
New Position
0.03%
$53,510
20,502 shares@ $2.61 avg price
BJDXBluejay Diagnostics Inc
Recent Activity
New Position
0.03%
$38,763
305,224 shares@ $0.13 avg price
REVBRevelation Biosciences Inc
Recent Activity
New Position
0.02%
$35,968
42,226 shares@ $0.86 avg price
SPCBSupercom Ltd
Recent Activity
New Position
0.02%
$35,194
9,360 shares@ $3.77 avg price
KPRXKiora Pharmaceuticals Inc
Recent Activity
New Position
0.01%
$18,300
5,000 shares@ $3.66 avg price
7615⤦Reviva Pharmaceutcls Hldgs I
Recent Activity
New Position
0.01%
$13,536↓ Put
94 shares@ $144.0 avg price
BCANFemto Technologies Inc
Recent Activity
New Position
0.01%
$7,197
898 shares@ $8.02 avg price
8088⤦Scilex Holding Co
Recent Activity
New Position
0.01%
$3,976↓ Put
43 shares@ $92.47 avg price